Kenya Biobanks Market Report 2023 to 2030

Kenya Biobanks Market Analysis

$ 3999

The Kenya Biobanks Market was valued at $53.72 Mn in 2023 and is predicted to grow at a CAGR of 9.90% from 2023 to 2030, to $104.02 Mn by 2030. The key drivers of this industry include disease burden, increasing biomedical research activities, and the growth of personalized medicine. The industry is primarily dominated by players such as Merck KGaA, QIAGEN, Tecan Group, and Becton, Dickinson and Company among others.

ID: IN10KEHS058 CATEGORY: Healthcare Services GEOGRAPHY: Kenya AUTHOR: Aashwi Mehta

Buy Now

Kenya Biobanks Market Executive Summary

The Kenya Biobanks Market was valued at $53.72 Mn in 2023 and is predicted to grow at a CAGR of 9.90% from 2023 to 2030, to $104.02 Mn by 2030.

A biobank is a curated collection of mainly human biological samples and related data systematically organized for research purposes. These facilities play a crucial role in medical research, supporting various contemporary studies such as genomics and personalized medicine. The types of samples and information gathered vary based on each biobank's specific objectives. For instance, some biobanks focus on specific diseases like cancer, while others are population-based, comprising samples and data from individuals within a particular demographic or geographic area.

A study in 2023 revealed that 95% of participants from Kenya and Tanzania were willing to share their biological samples with researchers. Additionally, data from the World Report shows that Kenya received 8% of the total biomedical research grants distributed across Africa. The market is driven by significant factors like disease burden, increasing biomedical research activities, and growth of personalized medicine. However, economic constraints, data privacy issues, and limited public awareness restrict the growth and potential of the market.

Prominent players in this field include Merck KGaA, QIAGEN, Tecan Group, and Becton, Dickinson and Company among others.

Kenya Biobanks Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Disease Burden: The increasing mortality rates from non-communicable diseases (NCDs) in Kenya, with age-standardized rates exceeding 600 per 100,000 for males and 500 per 100,000 for females across major NCDs, drive the biobank market. This high burden of NCDs underscores the need for extensive research and data collection to better understand and address these conditions, fueling demand for biobank facilities and services.

Increasing Biomedical Research Activities: The surge in biomedical research activities drives demand for biobanking services in Kenya. As researchers address local health challenges, biobanks are essential for storing samples used in studies on infectious diseases, genetic disorders, and chronic illnesses, boosting market growth.

Growth of Personalized Medicine: The growth of personalized medicine drives the biobank market in Kenya by increasing the need for extensive genetic and biological data. Personalized medicine relies on detailed biological information to tailor treatments to individual patients, which requires robust biobanking infrastructure to collect, store, and manage this data effectively.

Market Restraints

Economic Constraints: The high initial costs needed to set up biobanking facilities pose a significant financial barrier. This challenge can discourage new market entrants and make it difficult for smaller or emerging companies to compete effectively in Kenya's biobank sector.

Data Privacy Issues: Maintaining the security and confidentiality of genetic data is essential. Fears about data privacy and possible breaches can undermine public trust and lead to decreased participation, which acts as a restraint on the biobank market in Kenya.

Limited Public Awareness: A lack of awareness about the benefits and significance of biobanks among the public can result in lower participation rates and fewer sample donations. This limited understanding acts as a market restraint for the biobank sector in Kenya by hindering the collection of vital biological samples.

Regulatory Landscape and Reimbursement Scenario

The National Guidelines for Ethical Conduct of Biomedical Research Involving Human Participants offer a detailed framework for regulating biobanking in Kenya. They stress the importance of obtaining ethical clearance from accredited Institutional Ethics Review Committees (IERCs) before conducting any biomedical research involving human samples.

Competitive Landscape

Key Players

Here are some of the major key players in the Kenya Biobanks Market:

Merck KGaA
QIAGEN
Tecan Group
Becton, Dickinson and Company
Beckman Coulter
BioLife Solutions
Next Biobank
FIND
Future Health Biobank
Greiner Bio-One

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Kenya Biobanks Market Segmentation

By Product and Service

Equipment
Consumables
Services

By Sample Type

Blood Products
Human Tissues
Nucleic Acids
Others

By Application

Regenerative Medicine
Life Science Research
Clinical Research
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.